<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000487473"><TermName>Zometa</TermName><TermPronunciation>(ZOH-meh-tuh)</TermPronunciation><TermDefinition><DefinitionText>A drug used to treat patients with hypercalcemia (high blood levels of calcium) caused by cancer. It is also used together with other drugs to treat multiple myeloma and to prevent bone fractures and reduce bone pain in people who have cancer that has spread to the bone. It is a type of bisphosphonate. Also called zoledronate and zoledronic acid.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718049" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Zometa&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718048" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Zometa&quot;" language="es" id="_4"/><SpanishTermName>Zometa</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar pacientes con hipercalcemia (concentración alta de calcio en la sangre) a causa del cáncer. Asimismo, se usa junto con otros medicamentos para tratar el mieloma múltiple y para prevenir las fracturas de los huesos y reducir el dolor de huesos en los pacientes cuyo cáncer se diseminó hasta los huesos. Es un tipo de bisfosfonato. También se llama ácido zoledrónico y zoledronato.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-06-16</DateFirstPublished><DateLastModified>2007-02-20</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000505465">Zoledronic Acid</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
